BSEInsider Trading / SAST1h ago · 23 Oct 2026, 10:08 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd
Biogen Pharmachem Industries Ltd · 531752
✦ AI SummaryRelated Party
Biogen Pharmachem Industries Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Rama Shiva Lease Finance Private Limited, indicating a change in shareholding in the company.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Attachments (1)
📄pdf
Download →
CC7DF2A3_5081_4227_8913_90596006FF6B_100818.pdf
View document text
RAMA SHIVA LEASE FINANCE PRIVATE LIMITED
CIN: U65910GJ1995PTC024753
Reg. Office Address: 24 LAXMI CHAMBERS, NAVJIVAN PRESS ROAD OPP OLD GUJARAT HIGH COURT AHMEDABAD - 380014
Through E-Mail
Date: 22.10.2026
Department of Corporate Services,
BSE Limited
P. J. Towers, Dalal Street,
Mumbai- 400001
Dear Sir,
Sub: Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares
and Takeovers) Regulations, 2011
Ref: Scrip Code: 531752 Scrip ID: BIOGEN
We are sending herewith Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of
Shares and Takeovers) Regulations, 2011.
Please find above in order and acknowledge the same.
Thanking You.
Yours faithfully,
For, Rama Shiva Lease Finance Private Limited
RAMASHIVA @H FINANCE (P.) LTD.
“AGEROFESEigHH:
c.C.
Compliance Officer
Biogen Pharmachem Industries Limited
Shop No. 8, First Floor, Makers - 1 Building, Jawahar Road, Rajkot-360001
E mail: suntechnooverseas@gmail.com
Format for Disclosures under Regulation 29(2) of
SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
1 | Name of the Target Company (TC) Biogen Pharmachems Industries Limited (BSE Security Code:
531752)
2 | Name(s) of the aequirer/Seller and
RAMA SHIVA LEASE FINANCE PRIVATE LIMITED
Persons Acting in Concert (PAC)
with the acquirer
3 | Whether the acquirer belongs No
to Promoter/Promoter group
4 | Name(s) of the Stock Exchange(s) BSE Limited
where the shares of TC are Listed
5 | Details of the acquisition/ Number % w.rt. total % w.rt total diluted
disposal/holding of shares/voting share/voting share/voting capital of the
rights/holding of the Acquirer capital Tc(*)
wherever
and PAC
applicable
Before the aequisition/disposal under consideration, holding of:
a) Shares carrying voting rights 4,25,83,333 4.04 4.04
b) Shares in the nature of 00 00 00
encumbrance (pledge/ lien/ non-
disposal undertaking/ others)
00 00
c) Voting rights (VR) otherwise
than by shares
d) Warrants/convertible 00 00
securities/any other instrument
that entitles the acquirer to
receive shares carrying voting
rights in the T C (specify holding in
each category)
4,25,83,333 4.04 4.04
Total (a+b+c)
Details of acquisition/sale
a) Shares carrying voting rights 4,25,83,333 4.04 4.04
acquired/sold
00 00
b) VRs acquired /sold
otherwise than by shares
c)Warrants/convertible 00 00 00
securities/any other instrument
that entitles the acquirer to
receive shares carrying voting rights
in the TC (specify holding in each
category) acquired/sold
d) Shares in the nature of
encumbrance (pledge/ lien/ non-
disposal undertaking/ others)
4,25,83,333 4.04 4.04
Total (a+b+c)
RAMASHIVA LEASE WANCE (P LTD-
After the-acquisition/sale, holding of:
a) Shares carrying voting rights 00 00 00
b) VRs otherwise than by shares 00 00 00
c) Warrants/convertible securities/any other 00 00 00
instrument that entitles the acquirer to
receive shares carrying voting rights in the
TC (specify holding in each category) after
acquisition.
d) Shares in the nature of encumbrance 00 00 00
(pledge/ lien/ non-disposal undertaking/
others)
Total (a+b+c) 00 00 00
6 | Mode of acquisition / sale (e.g. open market
/ off-market / public issue / rights issue / | Open Market
preferential allotment / inter-se transfer
etc).
7 | Date of acquisition / sale of shares / VR or | 16.10.2026
date of receipt of intimation of allotment
of shares, whichever is applicable
8 | Equity share capital / total voting capital | Rs.1,05,30,36,833 /- divided in to 1053036833
of the TC before the said acquisition / sale | Equity share of Rs. 1/- each.
9 | Equity share capital/ total voting capital | Rs.1,05,30,36,833 divided in to 1053036833
of the TC after the said acquisition / sale | Equity share of Rs. 1/- each.
10 | Total diluted share/voting capital of the TC | Rs.1,05,30,36,833 /- divided in to 1053036833
after the said acquisition/sale. Equity share of Rs. 1/- each.
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of
the outstanding convertible securities/warrants into equity shares of the TC.
SEFINANCE PRIVATE LIMITED